Found: 77
Select item for more details and to access through your institution.
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 1, p. e259, doi. 10.1210/clinem/dgad431
- By:
- Publication type:
- Article
Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2007, v. 9, p. 23, doi. 10.1111/j.1463-1326.2007.00765.x
- By:
- Publication type:
- Article
GLP-1 derivative liraglutide in rats with Β-cell deficiencies: influence of metabolic state on Β cell dynamics.
- Published in:
- British Journal of Pharmacology, 2003, v. 140, n. 1, p. 123, doi. 10.1038/sj.bjp.0705397
- By:
- Publication type:
- Article
Potential of liraglutide in the treatment of patients with type 2 diabetes.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Potential of liraglutide in the treatment of patients with type 2 diabetes.
- Published in:
- Vascular Health & Risk Management, 2009, v. 5, p. 199
- By:
- Publication type:
- Article
Small Intestinal Glucose Delivery Affects the Lowering of Blood Glucose by Acute Vildagliptin in Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Incretin effect after oral amino Acid ingestion in humans.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Incretin Hormone and Insulin Responses to Oral Versus Intravenous Lipid Administration in Humans.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 8, p. 2519, doi. 10.1210/jc.2011-0266
- By:
- Publication type:
- Article
Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as “Isoglycemic” Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 4, p. 945, doi. 10.1210/jc.2010-2178
- By:
- Publication type:
- Article
Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion.
- Published in:
- Journal of Diabetes Research, 2015, p. 1, doi. 10.1155/2016/8352957
- By:
- Publication type:
- Article
Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 2017, doi. 10.1111/dom.14789
- By:
- Publication type:
- Article
Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1182, doi. 10.1111/dom.14673
- By:
- Publication type:
- Article
Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 806, doi. 10.1111/dom.14636
- By:
- Publication type:
- Article
Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2009, doi. 10.1111/dom.14422
- By:
- Publication type:
- Article
Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 415, doi. 10.1111/dom.14233
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 10.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1, doi. 10.1111/dom.14188
- By:
- Publication type:
- Article
No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1837, doi. 10.1111/dom.14106
- By:
- Publication type:
- Article
Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1937, doi. 10.1111/dom.13321
- By:
- Publication type:
- Article
A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 34, doi. 10.1111/dom.13135
- By:
- Publication type:
- Article
Do we know the true mechanism of action of the DPP-4 inhibitors?
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 34, doi. 10.1111/dom.13018
- By:
- Publication type:
- Article
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 200, doi. 10.1111/dom.12802
- By:
- Publication type:
- Article
Feedback suppression of meal-induced glucagon-like peptide-1 ( GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1100, doi. 10.1111/dom.12706
- By:
- Publication type:
- Article
Impact of Exogenous Hyperglucagonemia on Postprandial Concentrations of Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in Humans.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 8, p. 4061, doi. 10.1210/jc.2010-0550
- By:
- Publication type:
- Article
Secretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 2, p. 872, doi. 10.1210/jc.2009-2054
- By:
- Publication type:
- Article
Preserved Inhibitory Potency of GLP-1 on Glucagon Secretion in Type 2 Diabetes Mellitus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 12, p. 4679, doi. 10.1210/jc.2009-0921
- By:
- Publication type:
- Article
Differential Islet and Incretin Hormone Responses in Morning Versus Afternoon after Standardized Meal in Healthy Men.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 8, p. 2887, doi. 10.1210/jc.2009-0366
- By:
- Publication type:
- Article
Hyperglycemia Acutely Lowers the Postprandial Excursions of Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide in Humans.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 4, p. 1379, doi. 10.1210/jc.2008-2197
- By:
- Publication type:
- Article
The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 4, p. 1249, doi. 10.1210/jc.2006-1882
- By:
- Publication type:
- Article
Normal Secretion and Action of the Gut Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Young Men with Low Birth Weight.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 8, p. 4912, doi. 10.1210/jc.2005-0382
- By:
- Publication type:
- Article
Degradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact Peptide.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 10, p. 3575, doi. 10.1210/jcem.85.10.6855
- By:
- Publication type:
- Article
Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism.
- Published in:
- Journal of the Endocrine Society, 2021, v. 5, n. 9, p. 1, doi. 10.1210/jendso/bvab084
- By:
- Publication type:
- Article
Impact of dipeptidyl peptidase-4 inhibitors on glucosedependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1203187
- By:
- Publication type:
- Article
Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 1, p. 75, doi. 10.1530/EJE-21-1187
- By:
- Publication type:
- Article
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans.
- Published in:
- European Journal of Endocrinology, 2014, v. 170, n. 4, p. 529, doi. 10.1530/EJE-13-0941
- By:
- Publication type:
- Article
Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty.
- Published in:
- European Journal of Endocrinology, 2013, v. 169, n. 2, p. 187, doi. 10.1530/EJE-13-0264
- By:
- Publication type:
- Article
What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.694284
- By:
- Publication type:
- Article
Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion.
- Published in:
- Disease Markers, 2015, p. 1, doi. 10.1155/2016/8352957
- By:
- Publication type:
- Article
Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans.
- Published in:
- Applied Physiology, Nutrition & Metabolism, 2008, v. 33, n. 5, p. 929, doi. 10.1139/H08-079
- By:
- Publication type:
- Article
GLP-1 Is a Coronary Artery Vasodilator in Humans.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Neurotensin secretion after Roux‐en‐Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty.
- Published in:
- Neurogastroenterology & Motility, 2022, v. 34, n. 1, p. 1, doi. 10.1111/nmo.14210
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of vildagliptin in patients with type 2 diabetes mellitus.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Pharmacokinetics and Pharmacodynamics of Vildagliptin in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Clinical Pharmacokinetics, 2007, v. 46, n. 7, p. 577, doi. 10.2165/00003088-200746070-00003
- By:
- Publication type:
- Article
Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls.
- Published in:
- Journal of Diabetes Investigation, 2010, v. 1, n. 1/2, p. 56, doi. 10.1111/j.2040-1124.2010.00010.x
- By:
- Publication type:
- Article
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0145890
- By:
- Publication type:
- Article
Differential GLP-1 Responses After Macronutrient Ingestion in Göttingen Minipigs.
- Published in:
- Diabetes, 2007, v. 56, p. A670
- By:
- Publication type:
- Article
Differential Intact Glucagon-Like Peptide-1 Release After Ingestion of Macronutrients in Healthy Subjects.
- Published in:
- Diabetes, 2007, v. 56, p. A373
- By:
- Publication type:
- Article
Stimulation of Insulin Secretion by Intravenous Bolus Injection and Continuous Infusion of Gastric Inhibitory Polypeptide in Patients With Type 2 Diabetes and Healthy ControlSubjects.
- Published in:
- Diabetes, 2004, v. 53, p. S220, doi. 10.2337/diabetes.53.suppl_3.S220
- By:
- Publication type:
- Article
Therapeutic strategies based on glucagon-like peptide 1.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
- Published in:
- 2004
- By:
- Publication type:
- journal article